EP1296710A4 - Recombinant vaccines against infectious bursal disease virus - Google Patents

Recombinant vaccines against infectious bursal disease virus

Info

Publication number
EP1296710A4
EP1296710A4 EP00937165A EP00937165A EP1296710A4 EP 1296710 A4 EP1296710 A4 EP 1296710A4 EP 00937165 A EP00937165 A EP 00937165A EP 00937165 A EP00937165 A EP 00937165A EP 1296710 A4 EP1296710 A4 EP 1296710A4
Authority
EP
European Patent Office
Prior art keywords
disease virus
vaccines against
bursal disease
infectious bursal
against infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00937165A
Other languages
German (de)
French (fr)
Other versions
EP1296710A1 (en
Inventor
Yehuda Stram
Arie Rogel
Orit Edelbaum
Ilan Sela
Yehuda Zanberg
Yehoshua Shachar
Eli Khayat
Tanya Gontmakher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rahan Meristem Ltd
Original Assignee
Rahan Meristem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rahan Meristem Ltd filed Critical Rahan Meristem Ltd
Publication of EP1296710A1 publication Critical patent/EP1296710A1/en
Publication of EP1296710A4 publication Critical patent/EP1296710A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
EP00937165A 2000-06-19 2000-06-19 Recombinant vaccines against infectious bursal disease virus Withdrawn EP1296710A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2000/000360 WO2001097839A1 (en) 2000-06-19 2000-06-19 Recombinant vaccines against infectious bursal disease virus

Publications (2)

Publication Number Publication Date
EP1296710A1 EP1296710A1 (en) 2003-04-02
EP1296710A4 true EP1296710A4 (en) 2004-05-12

Family

ID=11042982

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00937165A Withdrawn EP1296710A4 (en) 2000-06-19 2000-06-19 Recombinant vaccines against infectious bursal disease virus

Country Status (3)

Country Link
EP (1) EP1296710A4 (en)
AU (1) AU2000252449A1 (en)
WO (1) WO2001097839A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368602B1 (en) * 2000-06-16 2002-04-09 Hadasit Medical Research Services And Development Ltd Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine
ES2307346B1 (en) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas EMPTY CAPSIDES (VLPS (-VP4)) OF THE VIRUS CAUSING THE INFECTIOUS BURSITIS DISEASE (IBDV), ITS PROCESSING PROCEDURE AND APPLICATIONS.
ES2310062B1 (en) 2005-07-15 2009-11-13 Bionostra, S.L. PSEUDOVIRAL PARTICLES CHEMICAL EMPTY DERIVED FROM VIRUS CAUSING INFECTIOUS BURSITIS DISEASE (IBDV), PROCEDURE OF OBTAINING AND APPLICATIONS.
CN112442131B (en) * 2019-08-28 2022-08-12 中国农业科学院生物技术研究所 Self-assembly ferritin-based nano antigen particle, infectious bursal disease vaccine prepared from self-assembly ferritin-based nano antigen particle and application of infectious bursal disease vaccine
WO2023227599A1 (en) 2022-05-23 2023-11-30 Atlantic Technological University Antimicrobial coating composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054126A (en) * 1985-05-30 2000-04-25 Commonwealth Scientific And Industrial Research Organization Cloning and expression of host-protective immunogens of IBDV

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5641490A (en) * 1991-03-07 1997-06-24 Virogenetics Corporation Infectious bursal disease virus recombinant poxvirus vaccine
US5605792A (en) * 1993-11-04 1997-02-25 The Ohio State University Research Foundation Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054126A (en) * 1985-05-30 2000-04-25 Commonwealth Scientific And Industrial Research Organization Cloning and expression of host-protective immunogens of IBDV

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
CICEK-M ET AL.: "Expression of soluble and catalytically active plant (monocot) beta-glucosidases in E. coli.", BIOTECHNOL BIOENG, vol. 63, no. 40, 20 May 1999 (1999-05-20), pages 392-400 *
FERNÁNDEZ-ARIAS A ET AL: "Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles.", THE JOURNAL OF GENERAL VIROLOGY. ENGLAND MAY 1998, vol. 79 ( Pt 5), May 1998 (1998-05-01), pages 1047 - 1054, XP002269599, ISSN: 0022-1317 *
FODOR I ET AL: "Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens", ACTA VETERINARIA HUNGARICA, vol. 47, no. 4, 1999, pages 481 - 492, XP000907298, ISSN: 0236-6290 *
JAGADISH-MN ET AL.: "Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide", JOURNAL OF VIROLOGY, vol. 62, no. 3, March 1988 (1988-03-01), pages 1084 - 1087, XP002269600 *
JAGADISH-MN ET AL.: "Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide.", J VIROL., vol. 62, no. 3, March 1988 (1988-03-01), pages 1084-1087 *
KIBENGE F S B ET AL: "Formation of virus-like particles when the polyprotein gene (Segment A) of infectious bursal disease virus in expressed in insect cells", CANADIAN JOURNAL OF VETERINARY RESEARCH, vol. 63, no. 1, January 1999 (1999-01-01), pages 49 - 55, XP009025615, ISSN: 0830-9000 *
MACREADIE I G ET AL: "PASSIVE PROTECTION AGAINST INFECTIOUS BURSAL DISEASE VIRUS BY VIRAL VP2 EXPRESSED IN YEAST", VACCINE, vol. 8, no. 6, 1990, pages 549 - 552, XP009026170, ISSN: 0264-410X *
MASON-HS, TRANSGENIC PLANTS AS VACCINE PRODUCTION SYSTEMS, vol. 13, September 1995 (1995-09-01), pages 388-392 *
See also references of WO0197839A1 *
TACKET-CO ET AL., HUMAN IMMUNE RESPONSES TO A NOVEL NORWALK VIRSU VACCINE DELIVERED IN TRANSGENIC POTATOES, vol. 182, pages 302 - 305 *
VAKHARIA V N ET AL: "Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins", VACCINE, vol. 12, no. 5, 1994, pages 452 - 456, XP009026169, ISSN: 0264-410X *
WALMSLEY AMANDA M ET AL: "Plants for delivery of edible vaccines", CURRENT OPINION IN BIOTECHNOLOGY, vol. 11, no. 2, April 2000 (2000-04-01), pages 126 - 129, XP002269601, ISSN: 0958-1669 *

Also Published As

Publication number Publication date
WO2001097839A1 (en) 2001-12-27
AU2000252449A1 (en) 2002-01-02
EP1296710A1 (en) 2003-04-02

Similar Documents

Publication Publication Date Title
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
GB2337755B (en) Virus vaccine
DE60219865D1 (en) Herpesvirus-based recombinant infectious bursal disease vaccine
HUS1500047I1 (en) Vaccine against the nile fever virus
IL150961A0 (en) Human immunodeficiency virus vaccine
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
IL147605A0 (en) Mosaic infectious bursal disease virus vaccines
HUP0302265A3 (en) A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
EP0597016A4 (en) Infectious bursal disease virus recombinant poxvirus vaccine.
EP1399481A4 (en) Recombinant antibodies against infectious bursal disease virus (ibdv)
IL131212A0 (en) Recombinant virus and live-virus vaccines
EP1389043A4 (en) Foot and mouth disease virus vaccine
IL177903A (en) Infectious bursal disease virus vaccine and use thereof
EP1296710A4 (en) Recombinant vaccines against infectious bursal disease virus
ATE392903T1 (en) VACCINE AGAINST EQUINE HERPES VIRUS
DK1248650T3 (en) Enhanced bovine herpes virus DNA vaccines 1
PL372453A1 (en) An infectious bursal disease virus variant
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
AU5098700A (en) Dna vaccine for protecting an avian against infectious bursal disease virus
IL179422A0 (en) Recombinant vaccines against infectious bursal disease virus
IL136859A0 (en) Recombinant vaccines against infectious bursal disease virus
HUP0102823A3 (en) A broad spectrum infectious bursal disease virus vaccine
EP1490396A4 (en) Immunogenic hiv peptides for use as reagents and vaccines
IS2797B (en) Vaccine against ISA virus

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/82 B

Ipc: 7C 12N 15/70 B

Ipc: 7C 12N 7/04 B

Ipc: 7C 07K 14/08 B

Ipc: 7A 61K 39/12 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040324

17Q First examination report despatched

Effective date: 20040702

17Q First examination report despatched

Effective date: 20040702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080404